Skip to main content
SpringerLink
Log in

Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria

  • Conference paper
Chronically Evolving Viral Hepatitis

Part of the book series: Archives of Virology ((ARCHIVES SUPPL,volume 4))

Summary

In 12 of 54 (22%) patients with histologically verified hepatocellular carcinoma, antibodies to hepatitis C virus were found. In patients with hepatocellular carcinoma the frequency of anti-hepatitis C virus positivity was similar whether cirrhosis (6 of 22 patients (27%)) was present or not (2 of 15 (13%)). Out of 54, 23 patients (43%) were negative both for hepatitis B or C markers. Out of 53,22 (42%) had positive hepatitis B markers, 8 of 22 were HBsAg positive. Patients with hepatocellular carcinoma and cirrhosis had a higher percentage of hepatitis B virus markers than patients with cirrhosis without hepatocellular carcinoma. Out of 70 patients with cirrhosis but without hepatocellular carcinoma, 24 (34%) had antibodies to hepatitis C virus. Our data of similar frequencies of antibodies to hepatitis C virus in patients with hepatocellular carcinoma or with liver cirrhosis but without hepatocellular carcinoma indicate that at least in Austrian patients, hepatitis C virus infections are not an important factor for development of hepatocellular carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Beasley RP, Hwang Lu-Yu, Lin GC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet ii: 1129–1133

    Article  Google Scholar 

  2. Bruix J, Calvet X, Costa J, Ventura M, Bruguera M, Castillo R, Barrera JM, Ercilla G, Sanchez-Tapias JM, Vall M, Bru C, Rodes J (1989) Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet ii: 1004–1006

    Article  Google Scholar 

  3. Chiaramonte M, Farinati F, Fagiuoli S, Ongaro S, Aneloni V, De Maria N, Naccarato R (1990) Lancet 335: 301–302

    Google Scholar 

  4. Colombo M, Choo QL, Ninno ED, Dioguardi N, Kuo G, Donato MF, Tommasini MA, Houghton M (1989) Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet ii: 1006–1008

    Article  Google Scholar 

  5. Dazza MC, Meneses LV, Girard PM, Villaroel C, Brechot C, Larouzet B (1990) Hepatitis C virus antibody and hepatocellular carcinoma. Lancet 335: 1216

    Google Scholar 

  6. Ducreux M, Dussaix E, Briantais MJ, Jacques L, Buffet C, Pelletier G, Yvart J, Etienne LP (1990) Lancet 335: 301

    Google Scholar 

  7. Ferenci P, Dragosics B, Marosi L, Kiss F (1984) Relative incidence of primary liver cancer in cirrhosis in Austria. Etiological considerations. Liver 4: 7–14

    Google Scholar 

  8. Johnson PJ, Williams R (1990) Hepatitis C antibodies and hepatocellular carcinoma: new clues or a false trial? Editorial, J Natl Cancer Inst 82: 986–987

    Article  PubMed  CAS  Google Scholar 

  9. Kew MC, Houghton M, Choo QL, Kuo G (1990) Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 335: 873–874

    Article  PubMed  CAS  Google Scholar 

  10. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakamo Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter H J (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671–675

    Article  PubMed  CAS  Google Scholar 

  11. Levrero M, Tagger A, Balsano C, Marzio ED, Avantaggiati ML, Natoli G, Diop D, Villa E, Diodati G, Alberti A (1991) Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. J Hepatol 12: 60–63

    Article  PubMed  CAS  Google Scholar 

  12. Li JS, Tong SP, Vitvitski L, Trepo C (1992) Sequence analysis of PCR amplified hepatitis C virus cDNA from French non-A, non-B hepatitis patients. In: De Bac C, Gerlich WH, Taliani G (eds) Chronically evolving viral hepatitis. Springer, Wien, New York (Arch Virol, Suppl 4, pp 184–185)

    Chapter  Google Scholar 

  13. Munoz N, Bosch X (1987) Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG (eds) Neoplasms of the liver. Springer, Berlin Heidelberg New York Tokyo, pp 3–19

    Google Scholar 

  14. Sbolli G, Zanetti AR, Tanzi E, Cavanna L, Civardi G, Fornari F, Di Stasi M, Buscarini L (1990) Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. J Med Virol 30: 230–232

    Article  PubMed  CAS  Google Scholar 

  15. Simonetti RG, Cottone M, Craxi A, Pagliaro L, Rapicetta M, Chionne P, Costatino A (1989) Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet ii: 1338

    Article  Google Scholar 

  16. Weiss W (1984) Das primäre Leberkarzinom. Facultas, Wien, p 45

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I. Department of Gastroenterology and Hepatology, University of Vienna, Lazarettgasse 14, A-1090, Wien, Austria

    Dr. Martina Baur, G. Novacek & P. Ferenci

  2. II. Department of Gastroenterology and Hepatology, University of Vienna, Austria

    U. Hay

  3. Department of Chemotherapy, University of Vienna, Wien, Austria

    C. Dittrich

Authors
  1. Dr. Martina Baur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Hay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Novacek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Dittrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Ferenci
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Titolare II Cattedra Clinica, Malattie Tropicli e Infettive, Policlinico Umberto, Roma, Italy

    C. De Bac  & G. Taliani  & 

  2. Institut für Medizinische Virologie, Justus-Leibig-Universität, Giessen, Federal Republic of Germany

    W. H. Gerlich

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag

About this paper

Cite this paper

Baur, M., Hay, U., Novacek, G., Dittrich, C., Ferenci, P. (1992). Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria. In: De Bac, C., Taliani, G., Gerlich, W.H. (eds) Chronically Evolving Viral Hepatitis. Archives of Virology, vol 4. Springer, Vienna. https://doi.org/10.1007/978-3-7091-5633-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-5633-9_16

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82350-7

  • Online ISBN: 978-3-7091-5633-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation